Skip to content
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
BioTechGrid BioTechGrid
  • Home
  • Biotechnology
  • Medical Technology
  • Research
  • Genetics
  • Press Releases
    • Business Wire
    • GlobeNewswire
    • PRNewswire
  • Contact
  • Home
  • Biotechnology
  • Page 5
non-invasive-biomarkers-for-early-oral-cancer-detection-through-multiomics-approach
Posted inBiotechnology

Non-invasive biomarkers for early oral cancer detection through multiomics approach

July 30, 2026
Non-invasive biomarker-based approaches are urgently needed to support early identification and monitoring of Oral squamous cell carcinoma (OSCC) and its…
Read More
cuau-alloy-electrocatalyst-enables-biomass-upgrading-and-bipolar-hydrogen-production-at-ultralow-voltage
Posted inBiotechnology

CuAu alloy electrocatalyst enables biomass upgrading and bipolar hydrogen production at ultralow voltage

July 30, 2026
image: CuAu alloys with tailored compositions were integrated onto copper foam by a simple one-step electrodeposition method. The optimized Cu0.25Au0.75 catalyst…
Read More
wistar-scientists-identify-fructose-as-a-surprise-driver-of-cancer-spread
Posted inBiotechnology

Wistar scientists identify fructose as a surprise driver of cancer spread

July 30, 2026
image: (On Right) Dr. Katherine Aird with members of her lab view more  Credit: The Wistar Institute A new study from…
Read More
neonatal-transport-for-convalescing-infants:-occurrence-and-barriers-reported-by-providers
Posted inBiotechnology

Neonatal transport for convalescing infants: occurrence and barriers reported by providers

July 30, 2026
Womack-Martenson, L.S., Manning, S.E., Rohan, A. et al. Neonatal transport for convalescing infants: occurrence and barriers reported by providers. J…
Read More
Posted inBiotechnology

Attovia, Braveheart and Vogenx seek more than $500M across trio of IPOs

July 30, 2026
Attovia Therapeutics, Braveheart Bio and Vogenx have set target ranges for their IPOs, positioning the trio to collectively net more…
Read More
Posted inBiotechnology

Takeda scraps another phase 2 celiac disease therapy, narrowing pipeline to one

July 30, 2026
Takeda has dropped another celiac disease therapy from its phase 2 pipeline, leaving the company with just one shot at…
Read More
shaping-light-like-never-before-–-with-photonic-time-crystals
Posted inBiotechnology

Shaping light like never before – with photonic time crystals

July 30, 2026
image: A THz electromagnetic wave induces strong, fast temporal modulations that realize a photonic time crystal: a crystal lattice in time…
Read More
new-deal-mortgage-programmes-benefited-white-borrowers-disproportionately
Posted inBiotechnology

New-deal mortgage programmes benefited white borrowers disproportionately

July 30, 2026
We show that the Federal Housing Administration (FHA) and Veterans’ Administration (VA) mortgage programmes had few Black borrowers and proportionate…
Read More
ultrasensitive-detection-of-alpha-synuclein-oligomers-in-human-plasma-using-optimized-nano-quic
Posted inBiotechnology

Ultrasensitive detection of alpha-synuclein oligomers in human plasma using optimized nano-QuIC

July 30, 2026
Jeong, H., Christenson, P.R., Ahn, H. et al. Ultrasensitive detection of alpha-synuclein oligomers in human plasma using optimized nano-QuIC. npj…
Read More
perpendicular-switching-of-polarization-in-layered-ferroelectrics
Posted inBiotechnology

Perpendicular switching of polarization in layered ferroelectrics

July 30, 2026
Ferroelectric materials exhibit a spontaneous electric polarization that can be reversed by an electric field1, a property central to non-volatile…
Read More

Posts pagination

Previous page 1 … 3 4 5 6 7 … 1,823 Next page

Privacy Policy    Terms

Scroll to Top